Santa Cruz startup gets GREAT news: the US Food and Drug Administration (FDA) has granted it a Breakthrough Device Designation for its Patho- Seq assay.
Read More
We don’t only report the news, we make the news. Our news highlights and archive here.
Interested in getting 24,000+ eyeballs to view your company’s content? Become a Santa Cruz Works Partner or, see 3rd party content Sponsors.
Santa Cruz startup gets GREAT news: the US Food and Drug Administration (FDA) has granted it a Breakthrough Device Designation for its Patho- Seq assay.
Read More